Abstract:SUMMARY: Senile osteoporosis is mainly caused by reduced osteoblast differentiation and has become the leading cause of fractures in the elderly worldwide. Natural organics are emerging as a potential option for the prevention and treatment of osteoporosis. This study was designed to study the effect of resveratrol on osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) in osteoporosis mice. A mouse model of osteoporosis was established by subcutaneous injection of dexamethasone and treated with resveratrol administered by gavage. In vivo and in vitro, we used western blot to detect protein expression, and evaluated osteogenic differentiation of BMSCs by detecting the expression of osteogenic differentiation related proteins, calcium deposition, ALP activity and osteocalcin content. Resveratrol treatment significantly increased the body weight of mice, the level of serum Ca2+, 25(OH)D and osteocalcin, ration of bone weight, bone volume/total volume, trabecular thickness, trabecular number, trabecular spacing and cortical thickness in osteoporosis mice. In BMSCs of osteoporosis mice, resveratrol treatment significantly increased the expression of Runx2, osterix (OSX) and osteocalcin (OCN) protein, the level of calcium deposition, ALP activity and osteocalcin content. In addition, resveratrol treatment also significantly increased the expression of SIRT1, p-PI3K / PI3K and p-AKT / AKT in BMSCs of osteoporosis mice. In vitro, resveratrol increased the expression of SIRT1, p-PI3K / PI3K and p-AKT / AKT, Runx2, OSX and OCN protein, the level of calcium deposition, ALP activity and osteocalcin content in BMSCs in a concentration-dependent manner, while SIRT1 knockdown significantly reversed the effect of resveratrol. Resveratrol can attenuate osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells, and the mechanism may be related to the regulation of SIRT1/PI3K/AKT pathway. RESUMEN: La osteoporosis senil es causada principalmente por una diferenciacin reducida de osteoblastos y se ha convertido en la principal causa de fracturas en las personas mayores en todo el mundo. Los productos orgnicos naturales estn surgiendo como una opcin potencial para la prevencin y el tratamiento de la osteoporosis. Este estudio fue diseado para estudiar el efecto del resveratrol en la diferenciacin osteognica de las clulas madre mesenquimales de la mdula sea (BMSC) en ratones con osteoporosis. Se estableci un modelo de osteoporosis en ratones mediante inyeccin subcutnea de dexametasona y se trat con resveratrol administrado por sonda. In vivo e in vitro, utilizamos Western blot para detectar la expresin de protenas y evaluamos la diferenciacin osteognica de BMSC detectando la expresin de protenas relacionadas con la diferenciacin osteognica, la deposicin de calcio, la actividad de ALP y el contenido de osteocalcina. El tratamiento con resveratrol aument significativamente el peso corporal de los ratones, el nivel srico de Ca2+, 25(OH)D y osteocalcina, la proporcin de peso seo, el volumen seo/ volumen total, el espesor trabecular, el nmero trabecular, el espaciado trabecular y el espesor cortical en ratones con osteoporosis. En BMSC de ratones con osteoporosis, el tratamiento con resveratrol aument significativamente la expresin de las protenas Runx2, osterix (OSX) y osteocalcina (OCN), el nivel de deposicin de calcio, la actividad de ALP y el contenido de osteocalcina. Adems, el tratamiento con resveratrol tambin aument significativamente la expresin de SIRT1, p-PI3K/PI3K y p-AKT/AKT en BMSC de ratones con osteoporosis. In vitro, el resveratrol aument la expresin de las protenas SIRT1, p-PI3K/PI3K y p- AKT/AKT, Runx2, OSX y OCN, el nivel de deposicin de calcio, la actividad de ALP y el contenido de osteocalcina en BMSC de manera dependiente de la concentracin, mientras que La cada de SIRT1 revirti significativamente el efecto del resveratrol. El resveratrol puede atenuar la osteoporosis al promover la diferenciacin osteognica de las clulas madre mesenquimales de la mdula sea, y el mecanismo puede estar relacionado con la regulacin de la va SIRT1/PI3K/AKT.

Resveratrol enhances the protective effects of calcium supplements on spinal cord injury–induced osteoporosis by targeting the SIRT1/FOXO3a pathway

Resveratrol Treatment of Spinal Cord Injury in Rat Model.

Resveratrol Enhances the Efficacy of Combined BM-MSCs Therapy for Rat Spinal Cord Injury via Modulation of the Sirt-1/NF-κB Signaling Pathway

Efficacy of coenzyme Q10 in mitigating spinal cord injury-induced osteoporosis.

Protective Effects of Resveratrol on Osteoporosis Via Activation of the SIRT1-NF-κB Signaling Pathway in Rats.

A comprehensive study of long-term skeletal changes after spinal cord injury in adult rats

Chronic intermittent hypobaric hypoxia ameliorates osteoporosis after spinal cord injury through balancing osteoblast and osteoclast activities in rats

Resveratrol Improves Neuron Protection and Functional Recovery in Rat Model of Spinal Cord Injury

The Therapeutic Response to Alendronate in Postmenopausal Chinese Women with Osteoporosis and N740n Polymorphism of Low Density Lipoprotein Receptor Related Protein 5 (lrp5) Gene

Reversing the Imbalance in Bone Homeostasis Via Sustained Release of SIRT-1 Agonist to Promote Bone Healing under Osteoporotic Condition

Administration of low intensity vibration and a RANKL inhibitor, alone or in combination, reduces bone loss after spinal cord injury-induced immobilization in rats

Resveratrol improves neurological outcome and neuroinflammation following spinal cord injury through enhancing autophagy involving the AMPK/mTOR pathway

Resveratrol can improve spinal cord injury by activating Nrf2/HO-1 signaling pathway

Revisiting Resveratrol as an Osteoprotective Agent: Molecular Evidence from In Vivo and In Vitro Studies

Sclerostin Antibody Reverses the Severe Sublesional Bone Loss in Rats after Chronic Spinal Cord Injury

Pulsed Electromagnetic Fields Ameliorate Skeletal Deterioration in Bone Mass, Microarchitecture, and Strength by Enhancing Canonical Wnt Signaling-Mediated Bone Formation in Rats with Spinal Cord Injury

Resveratrol inhibits ferroptosis via activating NRF2/GPX4 pathway in mice with spinal cord injury

Resveratrol evokes neuroprotective effects and improves foot stance following kainate-induced excitotoxic damage to the mouse spinal cord

Treatment with curcumin alleviates sublesional bone loss following spinal cord injury in rats

Resveratrol Alleviates Osteoporosis by Promoting Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells via SITR1/PI3K/AKT Pathway

Resveratrol-primed exosomes strongly promote the recovery of motor function in SCI rats by activating autophagy and inhibiting apoptosis via the PI3K signaling pathway